<DOC>
	<DOCNO>NCT01341964</DOCNO>
	<brief_summary>Clopidogrel aspirin commonly use combination prevent heart attack prevent blockage stent . Both clopidogrel aspirin work prevent platelet ( sticky cell circulate blood ) form blood clot artery supply oxygen heart stent . The investigator hypothesize aspirin 325mg compare aspirin 81 mg increase blood level active metabolite clopidogrel patient history coronary artery disease receive 600mg load dose clopidogrel .</brief_summary>
	<brief_title>Clopidogrel Aspirin Interaction Study-2</brief_title>
	<detailed_description>Eligible patient randomize receive clopidogrel 600mg + aspirin 325mg ( Group A ) clopidogrel 600mg + aspirin 81mg ( Group B ) . Patients fast least 8 hour prior study drug administration . Blood sample collect 1 hour study drug administration measurement clopidogrel active metabolite level genotyping .</detailed_description>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<criteria>Stable patient &gt; 1 month post ACS ( include ST elevate myocardial infarction , nonST elevate myocardial infarction unstable angina ) stent Receiving regular ASA ( 81mg/d ) clopidogrel ( 75mg/d ) least 1 week Written inform consent Age &lt; 18 year Liver disease ALT bilirubin &gt; 2x upper limit normal ( ULN ) * Renal impairment creatinine clearance &lt; 30 ml/min* Deemed high risk bleeding ( e.g. , recent bleeding , platelet count &lt; 100x109/L hemoglobin &lt; 100g/L ) * Anticoagulant NSAID therapy within last 5 day Antiplatelet agent aspirin clopidogrel within last 10 day Uncontrolled hypertension ( &gt; =180/110mmHg ) within 3 month plan randomization</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Clopidogrel</keyword>
	<keyword>Aspirin</keyword>
	<keyword>Interaction</keyword>
</DOC>